The global demand for extraction kits is expected to increase at 7.1% CAGR over the forecast period. The extraction kits market size is estimated to reach a valuation of US$ 1,293.4 million by 2023. According to the study, DNA extraction kit products held a substantial share of 49.88% in 2022 in the global market.
Salient Factors Catalyzing the Market Growth Include:
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
An increasing number of research and development activities to develop vaccines to combat the diseases is expected to boost the market. Hence, key players are investing extensively to gain a competitive edge in the industry.
Other initiatives, such as the EMBO, and Young Investigator Program aids in the establishment of laboratories by life scientists. Under this initiative, the young researchers are expected to receive funding for four years. This is going to help them to establish their networking and training, enhancing their research development.
All research initiatives are projected to help the key players in the market to expand their footprints in emerging economies. Such situations are expected to help create attractive opportunities for local players to strengthen their position and increase their market share over the forecast period.
Key Factors Restraining the Extraction Kits Demand
| Data Points | Market Insights |
|---|---|
| Extraction Kits Industry Value 2022 | US$ 1,218.4 million |
| Extraction Kits Market Value 2023 | US$ 1,293.4 million |
| Extraction Kits Market Value 2033 | US$ 2,556.6 million |
| Extraction Kits Industry CAGR 2023 to 2033 | 7.1% |
| Market Share of Top 5 Countries | 56.5% |
According to Future Market Insights (FMI), the overall sales of extraction kits expanded at a CAGR of 7.4% between 2018 and 2022. However, the demand in the extraction kits industry is expected to increase at a CAGR of 7.1%, surpassing US$ 2,556.6 million by the end of 2033.
The global extraction kits market held around 5.0% of the global genome sequencing market, which was valued at nearly US$ 23 billion in the year 2021.
Market expansion is underpinned by growing innovation in molecular diagnostic techniques, resulting in the detection of numerous diseases. Integration of automation in these extraction systems is projected to simplify and improve the yield of nucleic acid extraction. For instance, Indian start-up 30M Genomics has developed a new extraction kit called AmpReady for extracting DNA from biological samples in five seconds without requiring any equipment. These kits offer accuracy and higher efficiency in analysis.
With a slew of advancements in automation for nucleic acid extraction, the market is projected to witness impressive growth over the coming years.
Rising investment by government bodies and other organizations for research and development activities in molecular diagnostics is likely to fuel the market. Increased funding for life science research and investments in molecular diagnostics is projected to fuel market growth.
According to UNESCO’s data, Germany spent about US$ 4 billion in 2021 to promote and boost research and development activities in the country. In China, the National Bureau of Statistics stated that China spent almost US$ 440.0 billion on research and development in 2021. As per the study, there was a 40% rise in spending as compared to 2020. As research and development funding activities are increasing across the globe, the extraction kits industry is poised to expand at a steady rate.
Based on product, DNA extraction kits were the dominant market segment in the global market in 2022, which contributed 49.88% of the revenue share. The global extraction kits market is expected to be valued at US$ 2,556.6 million by the end of 2033, registering a CAGR of 7.1% in the forecast period.
Principal Consultant
| Region | North America |
|---|---|
| Market Share % 2022 | 33.4% |
| Market Size (US$ million) by 2023 | US$ 431.99 million |
| Market Size (US$ million) by End of Forecast Period (2033) | US$ 853.90 million |
North America region held a market share of 33.4% in 2022. The market growth has been underpinned by several research and development activities. In addition to this, industry players are consistently updating their product portfolios, which is assessed to positively influence market trajectory. Other factors stimulating regional growth include:
| Region | Europe |
|---|---|
| Market Share % 2022 | 28.7% |
| Market Size (US$ million) by 2023 | US$ 371.2 million |
| Market Size (US$ million) by End of Forecast Period (2033) | US$ 733.74 million |
In 2022, Europe acquired a 28.7% market share in the global landscape. In the same year, the region gained US$ 371.2 million, and by 2033, the market is projected to gain US$ 733.74 million.
The large contribution of Europe in the global sphere is due to the accelerating patient population and beneficial government initiatives. Take for example, in 2020, Merck invested US$ 21.09 million to create a life sciences lab in Switzerland, Europe. This is projected to expedite and encourage research and development activities for the company, in addition to quality control and analytical production.
| Country | The United States |
|---|---|
| Market Share % 2022 | 31% |
| Market Size (US$ million) by 2023 | US$ 400.95 million |
| Market Size (US$ million) by End of Forecast Period (2033) | US$ 792.54 million |
According to Future Market Insights, the United States is expected to dominate North America, with a total market share of 92.8% in 2022. The country is projected to continue to exhibit high growth through 2023 and beyond.
In the global landscape, the United States’ share in the market stood maximum at 31% in 2022. In 2023, the market is assessed to amass a total of US$ 400.95 million. Similarly, by the forecast period’s end, the market is estimated to be valued at a maximum of US$ 792.54 million.
Technological advancements in the automation of DNA & RNA extraction across the United States is projected to drive product demand. For instance, Thermo Fischer Scientific launched the Thermo Scientific KingFisher Apex Purification System in April 2021.
| Country | Germany |
|---|---|
| Market Share % 2022 | 7.3% |
| Market Size (US$ million) by 2023 | US$ 94.41 million |
| Market Size (US$ million) by End of Forecast Period (2033) | US$ 186.63 million |
Germany is set to exhibit growth at a CAGR of 8.3% in Europe’s extraction kits market during the forecast period. Germany’s market captured 7.3% of the global market in 2022. By the end of the assessment period, the market is projected to be valued at a sum of US$ 186.63 million.
Increasing investment in research and development in Germany is uplifting the regional market status. Also, the development of new technologies for the fast detection of clinically important compounds is projected to facilitate market expansion.
| Country | China |
|---|---|
| Market CAGR % through till 2033 | 9.8% |
China is projected to expand at a CAGR rate of 9.8% during the forecast period, anticipating Future Market Insights (FMI). China is expected to spearhead the growth in East Asia due to technological advancement in the healthcare sector.
Key players in the country are working toward developing sophisticated automated systems for nucleic acid extraction. Consequently, augmenting the product’s demand in the market.
Get the data you need at a Fraction of the cost
Personalize your report by choosing insights you need
and save 40%!
| Segment | DNA Extraction Kits |
|---|---|
| Market Share (2022) | 49.88% |
| Market Size (2023) | US$ 645.14 million |
| Market Size (2033) | US$ 1,275.23 million |
The DNA extraction kits contributed about 49.88% of the market share in 2022 and are expected to register a CAGR of 7.4% in the forecast period. The availability of a wide range of robust kits and ease of application in various molecular biology applications for the detection of nucleic acids in cancerous tissues is projected to aid segment growth.
Nearly 2 out of 5 Extraction Kits Sales Come from Disease Diagnosis
| Segment | Disease Diagnosis |
|---|---|
| Market Share (2022) | 37.08% |
| Market Size (2023) | US$ 479.59 million |
| Market Size (2033) | US$ 947.98 million |
In terms of application, the disease diagnosis segment is expected to hold a 37.08% share in revenue, exhibiting growth at 7.8% CAGR in the forecast period. The increasing prevalence of chronic diseases, genetic disorders, and cancer has led to an increase in the use of DNA & RNA extraction kits. This is projected to contribute to the market expansion in the forecast period.
Burgeoning Need for Nucleic Acid Extraction Kits in Diagnostic Laboratories to Propel the Sales
Based on end users, the diagnostic laboratories segment held a market share of more than 29.9% in 2022 and is poised to expand at a CAGR of 7.9% over the upcoming decade. Demand for extraction kits in diagnostic laboratories is increasing due to the high adoption of nucleic acid extraction kits for identifying and characterizing microbes. These microbes are the prime cause of certain chronic ailments.
Key Developments in the Extraction Kits Market:
| Attribute | Details |
|---|---|
| Forecast Period | 2023 to 2033 |
| Historical Data Available for | 2018 to 2022 |
| Market Analysis | US$ million for Value |
| Key Regions Covered | North America; Latin America; Europe; South Asia; East Asia; Oceania; and the Middle East & Africa |
| Key Countries Covered | The United States, Canada, Brazil, Mexico, Argentina, Germany, the United Kingdom, France, Italy, Spain, Russia, BENELUX, China, Japan, South Korea, India, Thailand, Indonesia, Malaysia, Australia, New Zealand, North Africa, GCC Countries, Türkiye, and South Africa |
| Key Market Segments Covered | Product, Application, End User, and Region |
| Key Companies Profiled | Bio Rad Laboratories Inc.; Thermo Fisher Scientific; Promega Corporation; Agilent Technologies; Bioneer Corporation; PerkinElmer Inc.; LGC Biosearch Technologies; Qiagen; General Biosystems; Takara Bio Inc.; Roche Life Science; GeneReach Biotechnology Corporation.; Merck Millipore; BioFire Defense LLC; Akonni Biosystems, Inc; Primerdesign Ltd. |
| Pricing | Available upon Request |
The market is estimated to secure a valuation of US$ 1,293.4 million in 2023.
The market is estimated to reach US$ 2,556.6 million by 2033.
Through 2033, the market is anticipated to expand at a 7.1% CAGR.
Enhancing government financing for the advancement of extraction technologies to establish new growth potential.
The United States has a substantial market share at 31%.
The DNA extraction kits accounted for about 49.88% of the market share.
The disease diagnosis category is set to rise at a 7.8% CAGR.
1. Executive Summary
1.1. Global Market Outlook
1.2. Demand-side Trends
1.3. Supply-side Trends
1.4. Technology Roadmap Analysis
1.5. Analysis and Recommendations
2. Market Overview
2.1. Market Coverage / Taxonomy
2.2. Market Definition / Scope / Limitations
3. Market Background
3.1. Market Dynamics
3.1.1. Drivers
3.1.2. Restraints
3.1.3. Opportunity
3.1.4. Trends
3.2. Scenario Forecast
3.2.1. Demand in Optimistic Scenario
3.2.2. Demand in Likely Scenario
3.2.3. Demand in Conservative Scenario
3.3. Opportunity Map Analysis
3.4. Product Life Cycle Analysis
3.5. Supply Chain Analysis
3.5.1. Supply Side Participants and their Roles
3.5.1.1. Producers
3.5.1.2. Mid-Level Participants (Traders/ Agents/ Brokers)
3.5.1.3. Wholesalers and Distributors
3.5.2. Value Added and Value Created at Node in the Supply Chain
3.5.3. List of Raw Material Suppliers
3.5.4. List of Existing and Potential Buyer’s
3.6. Investment Feasibility Matrix
3.7. Value Chain Analysis
3.7.1. Profit Margin Analysis
3.7.2. Wholesalers and Distributors
3.7.3. Retailers
3.8. PESTLE and Porter’s Analysis
3.9. Regulatory Landscape
3.9.1. By Key Regions
3.9.2. By Key Countries
3.10. Regional Parent Market Outlook
3.11. Production and Consumption Statistics
3.12. Import and Export Statistics
4. Global Market Analysis 2018 to 2022 and Forecast, 2023 to 2033
4.1. Historical Market Size Value (US$ Million) & Volume (Units) Analysis, 2018 to 2022
4.2. Current and Future Market Size Value (US$ Million) & Volume (Units) Projections, 2023 to 2033
4.2.1. Y-o-Y Growth Trend Analysis
4.2.2. Absolute $ Opportunity Analysis
5. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Product
5.1. Introduction / Key Findings
5.2. Historical Market Size Value (US$ Million) & Volume (Units) Analysis By Product, 2018 to 2022
5.3. Current and Future Market Size Value (US$ Million) & Volume (Units) Analysis and Forecast By Product, 2023 to 2033
5.3.1. DNA Extraction Kits
5.3.1.1. Sequence-specific DNA
5.3.1.2. Cell-free DNA (cfDNA)
5.3.1.3. Tissue DNA Extraction Kits
5.3.2. RNA extraction Kits
5.3.2.1. Total RNA
5.3.2.2. Purified RNAs
5.3.2.3. Viral RNA
5.3.2.4. Sequence-specific RNA
5.3.3. Total nucleic acid (RNA + DNA)
5.4. Y-o-Y Growth Trend Analysis By Product, 2018 to 2022
5.5. Absolute $ Opportunity Analysis By Product, 2023 to 2033
6. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Application
6.1. Introduction / Key Findings
6.2. Historical Market Size Value (US$ Million) & Volume (Units) Analysis By Application, 2018 to 2022
6.3. Current and Future Market Size Value (US$ Million) & Volume (Units) Analysis and Forecast By Application, 2023 to 2033
6.3.1. Disease Diagnosis
6.3.2. Drug Discovery
6.3.3. Cancer Research
6.3.4. cDNA Library
6.3.5. Others
6.4. Y-o-Y Growth Trend Analysis By Application, 2018 to 2022
6.5. Absolute $ Opportunity Analysis By Application, 2023 to 2033
7. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By End User
7.1. Introduction / Key Findings
7.2. Historical Market Size Value (US$ Million) & Volume (Units) Analysis By End User, 2018 to 2022
7.3. Current and Future Market Size Value (US$ Million) & Volume (Units) Analysis and Forecast By End User, 2023 to 2033
7.3.1. Hospitals
7.3.2. Academic and Research Institutions
7.3.3. Pharmaceutical and Biotechnology Companies
7.3.4. Clinical Research Organisations
7.3.5. Diagnostic Laboratories
7.3.6. Forensic Labs
7.4. Y-o-Y Growth Trend Analysis By End User, 2018 to 2022
7.5. Absolute $ Opportunity Analysis By End User, 2023 to 2033
8. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Region
8.1. Introduction
8.2. Historical Market Size Value (US$ Million) & Volume (Units) Analysis By Region, 2018 to 2022
8.3. Current Market Size Value (US$ Million) & Volume (Units) Analysis and Forecast By Region, 2023 to 2033
8.3.1. North America
8.3.2. Latin America
8.3.3. Europe
8.3.4. Asia Pacific
8.3.5. MEA
8.4. Market Attractiveness Analysis By Region
9. North America Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country
9.1. Historical Market Size Value (US$ Million) & Volume (Units) Trend Analysis By Market Taxonomy, 2018 to 2022
9.2. Market Size Value (US$ Million) & Volume (Units) Forecast By Market Taxonomy, 2023 to 2033
9.2.1. By Country
9.2.1.1. USA
9.2.1.2. Canada
9.2.2. By Product
9.2.3. By Application
9.2.4. By End User
9.3. Market Attractiveness Analysis
9.3.1. By Country
9.3.2. By Product
9.3.3. By Application
9.3.4. By End User
9.4. Key Takeaways
10. Latin America Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country
10.1. Historical Market Size Value (US$ Million) & Volume (Units) Trend Analysis By Market Taxonomy, 2018 to 2022
10.2. Market Size Value (US$ Million) & Volume (Units) Forecast By Market Taxonomy, 2023 to 2033
10.2.1. By Country
10.2.1.1. Brazil
10.2.1.2. Mexico
10.2.1.3. Rest of Latin America
10.2.2. By Product
10.2.3. By Application
10.2.4. By End User
10.3. Market Attractiveness Analysis
10.3.1. By Country
10.3.2. By Product
10.3.3. By Application
10.3.4. By End User
10.4. Key Takeaways
11. Europe Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country
11.1. Historical Market Size Value (US$ Million) & Volume (Units) Trend Analysis By Market Taxonomy, 2018 to 2022
11.2. Market Size Value (US$ Million) & Volume (Units) Forecast By Market Taxonomy, 2023 to 2033
11.2.1. By Country
11.2.1.1. Germany
11.2.1.2. UK
11.2.1.3. France
11.2.1.4. Spain
11.2.1.5. Italy
11.2.1.6. Rest of Europe
11.2.2. By Product
11.2.3. By Application
11.2.4. By End User
11.3. Market Attractiveness Analysis
11.3.1. By Country
11.3.2. By Product
11.3.3. By Application
11.3.4. By End User
11.4. Key Takeaways
12. Asia Pacific Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country
12.1. Historical Market Size Value (US$ Million) & Volume (Units) Trend Analysis By Market Taxonomy, 2018 to 2022
12.2. Market Size Value (US$ Million) & Volume (Units) Forecast By Market Taxonomy, 2023 to 2033
12.2.1. By Country
12.2.1.1. China
12.2.1.2. Japan
12.2.1.3. South Korea
12.2.1.4. Singapore
12.2.1.5. Thailand
12.2.1.6. Indonesia
12.2.1.7. Australia
12.2.1.8. New Zealand
12.2.1.9. Rest of Asia Pacific
12.2.2. By Product
12.2.3. By Application
12.2.4. By End User
12.3. Market Attractiveness Analysis
12.3.1. By Country
12.3.2. By Product
12.3.3. By Application
12.3.4. By End User
12.4. Key Takeaways
13. MEA Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country
13.1. Historical Market Size Value (US$ Million) & Volume (Units) Trend Analysis By Market Taxonomy, 2018 to 2022
13.2. Market Size Value (US$ Million) & Volume (Units) Forecast By Market Taxonomy, 2023 to 2033
13.2.1. By Country
13.2.1.1. GCC Countries
13.2.1.2. South Africa
13.2.1.3. Israel
13.2.1.4. Rest of MEA
13.2.2. By Product
13.2.3. By Application
13.2.4. By End User
13.3. Market Attractiveness Analysis
13.3.1. By Country
13.3.2. By Product
13.3.3. By Application
13.3.4. By End User
13.4. Key Takeaways
14. Key Countries Market Analysis
14.1. USA
14.1.1. Pricing Analysis
14.1.2. Market Share Analysis, 2022
14.1.2.1. By Product
14.1.2.2. By Application
14.1.2.3. By End User
14.2. Canada
14.2.1. Pricing Analysis
14.2.2. Market Share Analysis, 2022
14.2.2.1. By Product
14.2.2.2. By Application
14.2.2.3. By End User
14.3. Brazil
14.3.1. Pricing Analysis
14.3.2. Market Share Analysis, 2022
14.3.2.1. By Product
14.3.2.2. By Application
14.3.2.3. By End User
14.4. Mexico
14.4.1. Pricing Analysis
14.4.2. Market Share Analysis, 2022
14.4.2.1. By Product
14.4.2.2. By Application
14.4.2.3. By End User
14.5. Germany
14.5.1. Pricing Analysis
14.5.2. Market Share Analysis, 2022
14.5.2.1. By Product
14.5.2.2. By Application
14.5.2.3. By End User
14.6. UK
14.6.1. Pricing Analysis
14.6.2. Market Share Analysis, 2022
14.6.2.1. By Product
14.6.2.2. By Application
14.6.2.3. By End User
14.7. France
14.7.1. Pricing Analysis
14.7.2. Market Share Analysis, 2022
14.7.2.1. By Product
14.7.2.2. By Application
14.7.2.3. By End User
14.8. Spain
14.8.1. Pricing Analysis
14.8.2. Market Share Analysis, 2022
14.8.2.1. By Product
14.8.2.2. By Application
14.8.2.3. By End User
14.9. Italy
14.9.1. Pricing Analysis
14.9.2. Market Share Analysis, 2022
14.9.2.1. By Product
14.9.2.2. By Application
14.9.2.3. By End User
14.10. China
14.10.1. Pricing Analysis
14.10.2. Market Share Analysis, 2022
14.10.2.1. By Product
14.10.2.2. By Application
14.10.2.3. By End User
14.11. Japan
14.11.1. Pricing Analysis
14.11.2. Market Share Analysis, 2022
14.11.2.1. By Product
14.11.2.2. By Application
14.11.2.3. By End User
14.12. South Korea
14.12.1. Pricing Analysis
14.12.2. Market Share Analysis, 2022
14.12.2.1. By Product
14.12.2.2. By Application
14.12.2.3. By End User
14.13. Singapore
14.13.1. Pricing Analysis
14.13.2. Market Share Analysis, 2022
14.13.2.1. By Product
14.13.2.2. By Application
14.13.2.3. By End User
14.14. Thailand
14.14.1. Pricing Analysis
14.14.2. Market Share Analysis, 2022
14.14.2.1. By Product
14.14.2.2. By Application
14.14.2.3. By End User
14.15. Indonesia
14.15.1. Pricing Analysis
14.15.2. Market Share Analysis, 2022
14.15.2.1. By Product
14.15.2.2. By Application
14.15.2.3. By End User
14.16. Australia
14.16.1. Pricing Analysis
14.16.2. Market Share Analysis, 2022
14.16.2.1. By Product
14.16.2.2. By Application
14.16.2.3. By End User
14.17. New Zealand
14.17.1. Pricing Analysis
14.17.2. Market Share Analysis, 2022
14.17.2.1. By Product
14.17.2.2. By Application
14.17.2.3. By End User
14.18. GCC Countries
14.18.1. Pricing Analysis
14.18.2. Market Share Analysis, 2022
14.18.2.1. By Product
14.18.2.2. By Application
14.18.2.3. By End User
14.19. South Africa
14.19.1. Pricing Analysis
14.19.2. Market Share Analysis, 2022
14.19.2.1. By Product
14.19.2.2. By Application
14.19.2.3. By End User
14.20. Israel
14.20.1. Pricing Analysis
14.20.2. Market Share Analysis, 2022
14.20.2.1. By Product
14.20.2.2. By Application
14.20.2.3. By End User
15. Market Structure Analysis
15.1. Competition Dashboard
15.2. Competition Benchmarking
15.3. Market Share Analysis of Top Players
15.3.1. By Regional
15.3.2. By Product
15.3.3. By Application
15.3.4. By End User
16. Competition Analysis
16.1. Competition Deep Dive
16.1.1. Bio Rad Laboratories Inc.
16.1.1.1. Overview
16.1.1.2. Product Portfolio
16.1.1.3. Profitability by Market Segments
16.1.1.4. Sales Footprint
16.1.1.5. Strategy Overview
16.1.1.5.1. Marketing Strategy
16.1.1.5.2. Product Strategy
16.1.1.5.3. Channel Strategy
16.1.2. Thermo Fisher Scientific
16.1.2.1. Overview
16.1.2.2. Product Portfolio
16.1.2.3. Profitability by Market Segments
16.1.2.4. Sales Footprint
16.1.2.5. Strategy Overview
16.1.2.5.1. Marketing Strategy
16.1.2.5.2. Product Strategy
16.1.2.5.3. Channel Strategy
16.1.3. Promega Corporation
16.1.3.1. Overview
16.1.3.2. Product Portfolio
16.1.3.3. Profitability by Market Segments
16.1.3.4. Sales Footprint
16.1.3.5. Strategy Overview
16.1.3.5.1. Marketing Strategy
16.1.3.5.2. Product Strategy
16.1.3.5.3. Channel Strategy
16.1.4. Agilent Technologies
16.1.4.1. Overview
16.1.4.2. Product Portfolio
16.1.4.3. Profitability by Market Segments
16.1.4.4. Sales Footprint
16.1.4.5. Strategy Overview
16.1.4.5.1. Marketing Strategy
16.1.4.5.2. Product Strategy
16.1.4.5.3. Channel Strategy
16.1.5. Bioneer Corporation
16.1.5.1. Overview
16.1.5.2. Product Portfolio
16.1.5.3. Profitability by Market Segments
16.1.5.4. Sales Footprint
16.1.5.5. Strategy Overview
16.1.5.5.1. Marketing Strategy
16.1.5.5.2. Product Strategy
16.1.5.5.3. Channel Strategy
16.1.6. PerkinElmer Inc.
16.1.6.1. Overview
16.1.6.2. Product Portfolio
16.1.6.3. Profitability by Market Segments
16.1.6.4. Sales Footprint
16.1.6.5. Strategy Overview
16.1.6.5.1. Marketing Strategy
16.1.6.5.2. Product Strategy
16.1.6.5.3. Channel Strategy
16.1.7. LGC Biosearch Technologies
16.1.7.1. Overview
16.1.7.2. Product Portfolio
16.1.7.3. Profitability by Market Segments
16.1.7.4. Sales Footprint
16.1.7.5. Strategy Overview
16.1.7.5.1. Marketing Strategy
16.1.7.5.2. Product Strategy
16.1.7.5.3. Channel Strategy
16.1.8. Qiagen
16.1.8.1. Overview
16.1.8.2. Product Portfolio
16.1.8.3. Profitability by Market Segments
16.1.8.4. Sales Footprint
16.1.8.5. Strategy Overview
16.1.8.5.1. Marketing Strategy
16.1.8.5.2. Product Strategy
16.1.8.5.3. Channel Strategy
16.1.9. General Biosystems
16.1.9.1. Overview
16.1.9.2. Product Portfolio
16.1.9.3. Profitability by Market Segments
16.1.9.4. Sales Footprint
16.1.9.5. Strategy Overview
16.1.9.5.1. Marketing Strategy
16.1.9.5.2. Product Strategy
16.1.9.5.3. Channel Strategy
16.1.10. Takara Bio Inc.
16.1.10.1. Overview
16.1.10.2. Product Portfolio
16.1.10.3. Profitability by Market Segments
16.1.10.4. Sales Footprint
16.1.10.5. Strategy Overview
16.1.10.5.1. Marketing Strategy
16.1.10.5.2. Product Strategy
16.1.10.5.3. Channel Strategy
16.1.11. Roche Life Science
16.1.11.1. Overview
16.1.11.2. Product Portfolio
16.1.11.3. Profitability by Market Segments
16.1.11.4. Sales Footprint
16.1.11.5. Strategy Overview
16.1.11.5.1. Marketing Strategy
16.1.11.5.2. Product Strategy
16.1.11.5.3. Channel Strategy
16.1.12. GeneReach Biotechnology Corporation.
16.1.12.1. Overview
16.1.12.2. Product Portfolio
16.1.12.3. Profitability by Market Segments
16.1.12.4. Sales Footprint
16.1.12.5. Strategy Overview
16.1.12.5.1. Marketing Strategy
16.1.12.5.2. Product Strategy
16.1.12.5.3. Channel Strategy
16.1.13. Merck Millipore
16.1.13.1. Overview
16.1.13.2. Product Portfolio
16.1.13.3. Profitability by Market Segments
16.1.13.4. Sales Footprint
16.1.13.5. Strategy Overview
16.1.13.5.1. Marketing Strategy
16.1.13.5.2. Product Strategy
16.1.13.5.3. Channel Strategy
16.1.14. BioFire Defense LLC
16.1.14.1. Overview
16.1.14.2. Product Portfolio
16.1.14.3. Profitability by Market Segments
16.1.14.4. Sales Footprint
16.1.14.5. Strategy Overview
16.1.14.5.1. Marketing Strategy
16.1.14.5.2. Product Strategy
16.1.14.5.3. Channel Strategy
16.1.15. Akonni Biosystems, Inc
16.1.15.1. Overview
16.1.15.2. Product Portfolio
16.1.15.3. Profitability by Market Segments
16.1.15.4. Sales Footprint
16.1.15.5. Strategy Overview
16.1.15.5.1. Marketing Strategy
16.1.15.5.2. Product Strategy
16.1.15.5.3. Channel Strategy
16.1.16. Primerdesign Ltd.
16.1.16.1. Overview
16.1.16.2. Product Portfolio
16.1.16.3. Profitability by Market Segments
16.1.16.4. Sales Footprint
16.1.16.5. Strategy Overview
16.1.16.5.1. Marketing Strategy
16.1.16.5.2. Product Strategy
16.1.16.5.3. Channel Strategy
17. Assumptions & Acronyms Used
18. Research Methodology
Explore Healthcare Insights
View Reports
Extraction Kits Market
